Kindstar Globalgene Technology (HKSE:09960) Short-Term Debt

: HK$213 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

Kindstar Globalgene Technology's Short-Term Debt for the quarter that ended in Jun. 2023 was HK$213 Mil.

Kindstar Globalgene Technology's quarterly Short-Term Debt increased from Jun. 2022 (HK$0 Mil) to Dec. 2022 (HK$201 Mil) and increased from Dec. 2022 (HK$201 Mil) to Jun. 2023 (HK$213 Mil).

Kindstar Globalgene Technology's annual Short-Term Debt declined from Dec. 2020 (HK$47 Mil) to Dec. 2021 (HK$0 Mil) but then increased from Dec. 2021 (HK$0 Mil) to Dec. 2022 (HK$201 Mil).

Kindstar Globalgene Technology Short-Term Debt Historical Data

The historical data trend for Kindstar Globalgene Technology's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

295.03

47.42

201.01

167.24

Kindstar Globalgene Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt						-	-	201.01	213.18	167.24

Kindstar Globalgene Technology Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Kindstar Globalgene Technology Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology (HKSE:09960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN

Website

https://www.kindstar.com.cn

Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (HKSE:09960) Headlines

No Headlines